Dublin Adam H 13D/13G Filings for eFFECTOR Therapeutics, Inc. (EFTR)

Dublin Adam H 13D and 13G filings for eFFECTOR Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
5:14 pm
Purchase
2021-12-3113GEFFECTOR THERAPEUTICS INC
EFTR
Dublin Adam H92,841
7.100%
92,841increase
(New Position)
Filing